Scynexis CFO granted 100K options at $4.91

SCYNEXIS granted its CFO 100,000 stock options at a $4.91 strike price, vesting over four years subject to continued service.

Rhea-AI Filing Summary

SCYNEXIS INC (SCYX) reported that its Chief Financial Officer, Sanjay Subramanian, received a grant of stock options on September 9, 2026 to purchase 100,000 shares of common stock at an exercise price of $4.91 per share. These options expire on September 8, 2036 and vest 25% after one year, with the remainder vesting in equal monthly installments over the following 36 months, contingent on continued service.

Insider Trade Summary

Grant/Award: 100,000 shares

Grant/Award 1 txn

Insider Subramanian Sanjay

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	100,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 100,000 contracts (Direct)

Footnotes (1)

1. F1. 25% of the shares subject to this option vests on the one-year anniversary of the grant date with the remainder vesting in equal monthly installments for thirty-six (36) months thereafter, provided the Reporting Person continues to provide continuous services to the Issuer.

Key Figures

Options granted: 100,000 options Exercise price: $4.91 per share Underlying shares: 100,000 shares +4 more

7 metrics

Options granted 100,000 options Stock option grant to CFO on September 9, 2026

Exercise price $4.91 per share Conversion or exercise price of the stock options

Underlying shares 100,000 shares Common stock underlying the option grant

Options after transaction 100,000 options Total stock options held from this award following the grant

Vesting cliff 25% after 1 year Portion of options vesting on the one-year anniversary of grant

Remaining vesting period 36 months monthly Remainder of options vesting in equal monthly installments

Expiration date September 8, 2036 Option term end date

Key Terms

Stock Option (Right to Buy), exercise price, vesting, grant date, +1 more

5 terms

Stock Option (Right to Buy) financial

"The security title is listed as Stock Option (Right to Buy)."

exercise price financial

"The options have a conversion or exercise price of $4.91 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"25% of the shares subject to this option vests on the one-year anniversary."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

grant date financial

"25% vests on the one-year anniversary of the grant date."

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

expiration date financial

"The options have an expiration date of September 8, 2036."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SCYX report for its CFO?

SCYNEXIS reported that its Chief Financial Officer, Sanjay Subramanian, received a grant of stock options for 100,000 shares of common stock on September 9, 2026, as a compensation-related award rather than a market purchase.

What is the exercise price of the CFO’s new SCYX stock options?

The stock options granted to the SCYNEXIS CFO have an exercise price of $4.91 per share for the underlying common stock, as specified in the derivative security terms.

How many SCYX shares are covered by the CFO’s stock option grant?

The stock option grant to the SCYNEXIS CFO covers 100,000 underlying shares of common stock. Following this grant, the reported stock option holdings from this award total 100,000 options directly held.

What is the vesting schedule for the SCYX CFO’s stock options?

According to the footnote, 25% of the options vest on the one-year anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over 36 months, provided the CFO continues to provide continuous services to SCYNEXIS.

When do the SCYX CFO’s newly granted stock options expire?

The stock options granted to the SCYNEXIS CFO expire on September 8, 2036, giving a 10-year term from around the grant date before they can no longer be exercised.

Was the SCYX CFO’s option grant reported under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is unchecked, and there is no footnote indicating that the CFO’s stock option grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:02 PM Accepted by SEC EDGAR 09/11/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Subramanian Sanjay

(Last) (First) (Middle)

1 EVERTRUST PLAZA

13TH FLOOR

(Street)

JERSEY CITY NEW JERSEY 07302

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SCYNEXIS INC [ SCYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$4.91	09/09/2026		A		100,000		(1)	09/08/2036	Common Stock	100,000	$0.00	100,000	D

Explanation of Responses:

1. 25% of the shares subject to this option vests on the one-year anniversary of the grant date with the remainder vesting in equal monthly installments for thirty-six (36) months thereafter, provided the Reporting Person continues to provide continuous services to the Issuer.

	/s/ Robert F. Joyce Jr., by Power of Attorney	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)